Analyst Ratings for Gossamer Bio
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock, with two bullish and two somewhat bullish ratings. The average price target is $5.5, implying an upside from the current price of $1.25. However, this average has decreased by 21.43% from the previous average price target of $7.00.
July 26, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have given bullish ratings for Gossamer Bio, with an average price target of $5.5, indicating potential upside.
The bullish ratings from analysts indicate a positive outlook for Gossamer Bio. The average price target of $5.5, despite being a decrease from the previous target, still suggests an upside from the current price of $1.25. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100